Regenxbio
RGNX
RGNX
178 hedge funds and large institutions have $355M invested in Regenxbio in 2026 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 61 increasing their positions, 58 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
5% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 58
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
40% less capital invested
Capital invested by funds: $593M → $355M (-$238M)
Holders
178
Holding in Top 10
2
Calls
$3.78M
Puts
$2.36M
Top Buyers
| 1 | +$9.12M | |
| 2 | +$4.67M | |
| 3 | +$4.46M | |
| 4 |
IHAM
Integral Health Asset Management
New York
|
+$3.15M |
| 5 |
YIH
Y-Intercept (HK)
Hong Kong
|
+$2.89M |
Top Sellers
| 1 | -$4.53M | |
| 2 | -$3.91M | |
| 3 | -$3.61M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$3.26M |
| 5 |
MCM
Moore Capital Management
New York
|
-$2.88M |
